Publication | Closed Access

RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus

Protein GlycationMetabolic SyndromeDiabetes ManagementBiochemistryMedicineDiabetesRrr-alpha-tocopheryl Acetate SupplementationHyperlipidemiaDiabetes MellitusMetabolismPharmacologyAtherosclerosisDyslipidemiaOxidative Stress